184 related articles for article (PubMed ID: 31678855)
1. An antibiotic depleted microbiome drives severe Campylobacter jejuni-mediated Type 1/17 colitis, Type 2 autoimmunity and neurologic sequelae in a mouse model.
Brooks PT; Bell JA; Bejcek CE; Malik A; Mansfield LS
J Neuroimmunol; 2019 Dec; 337():577048. PubMed ID: 31678855
[TBL] [Abstract][Full Text] [Related]
2. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
[TBL] [Abstract][Full Text] [Related]
3. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
[TBL] [Abstract][Full Text] [Related]
4. Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity.
Malik A; Sharma D; St Charles J; Dybas LA; Mansfield LS
Mucosal Immunol; 2014 Jul; 7(4):802-17. PubMed ID: 24220299
[TBL] [Abstract][Full Text] [Related]
5. Effects of antibiotic resistance (AR) and microbiota shifts on Campylobacter jejuni-mediated diseases.
Brooks PT; Mansfield LS
Anim Health Res Rev; 2017 Dec; 18(2):99-111. PubMed ID: 29665882
[TBL] [Abstract][Full Text] [Related]
6. Th1/Th17-mediated Immunity and Protection from Peripheral Neuropathy in Wildtype and IL10
Brudvig JM; Cluett MM; Gensterblum-Miller EU; Chen J; Bell JA; Mansfield LS
Comp Med; 2022 Apr; 72(2):63-77. PubMed ID: 35272743
[No Abstract] [Full Text] [Related]
7.
Malik A; Brudvig JM; Gadsden BJ; Ethridge AD; Mansfield LS
Gut Microbes; 2022; 14(1):2064706. PubMed ID: 35442154
[No Abstract] [Full Text] [Related]
8. Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options.
Ebrahim Soltani Z; Rahmani F; Rezaei N
Eur Cytokine Netw; 2019 Mar; 30(1):1-14. PubMed ID: 31074417
[TBL] [Abstract][Full Text] [Related]
9. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice.
Haag LM; Fischer A; Otto B; Plickert R; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM
PLoS One; 2012; 7(5):e35988. PubMed ID: 22563475
[TBL] [Abstract][Full Text] [Related]
11. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
12. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
13. Murine Fecal Microbiota Transplantation Alleviates Intestinal and Systemic Immune Responses in
Heimesaat MM; Mrazek K; Bereswill S
Front Immunol; 2019; 10():2272. PubMed ID: 31616437
[TBL] [Abstract][Full Text] [Related]
14. Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome.
Huizinga R; van den Berg B; van Rijs W; Tio-Gillen AP; Fokkink WJ; Bakker-Jonges LE; Geleijns K; Samsom JN; van Doorn PA; Laman JD; Jacobs BC
Ann Neurol; 2015 Sep; 78(3):343-54. PubMed ID: 26017721
[TBL] [Abstract][Full Text] [Related]
15. Influence of the Gut Microbiota Composition on Campylobacter jejuni Colonization in Chickens.
Han Z; Willer T; Li L; Pielsticker C; Rychlik I; Velge P; Kaspers B; Rautenschlein S
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808158
[TBL] [Abstract][Full Text] [Related]
16. The immunobiology of Campylobacter jejuni: Innate immunity and autoimmune diseases.
Phongsisay V
Immunobiology; 2016 Apr; 221(4):535-43. PubMed ID: 26709064
[TBL] [Abstract][Full Text] [Related]
17. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
Yuki N; Koga M; Hirata K
Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
Shu XM; Cai FC; Zhang XP
Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide-binding oligomerization domain-containing protein 2 controls host response to Campylobacter jejuni in Il10-/- mice.
Sun X; Jobin C
J Infect Dis; 2014 Oct; 210(7):1145-54. PubMed ID: 24620022
[TBL] [Abstract][Full Text] [Related]
20. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]